Login to Your Account

Cell Therapeutics Makes Bid For DOR; Offer On Hold For Now

By Jennifer Boggs

Monday, January 22, 2007
DOR BioPharma Inc. said a buyout offer by Cell Therapeutics Inc. cannot be considered at this time due to the company's letter of intent with a potential partner for its lead program orBec, a corticosteroid pending regulatory approval in gastrointestinal graft-vs.-host disease. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription